

|



 |
|
Sunday, March 18, 2012 7:30 p.m. Convention Centre Ballroom C
|
- In Situ Breast Carcinoma - What's New? From Pathology to Clinical Management
|
|
Moderator:
|
Aysegul Sahin, University of Texas M. D. Anderson Cancer Center, Houston, TX
|




Click the button above to add this event to your Itinerary Planner...



| 7:30 |
Introduction and Award Presentation: - Ann Thor, University of Colorado, Denver, CO |
| 7:45 |
Ductal Carcinoma in Situ: MorphologyBased Knowledge and Molecular Advances - Edi Brogi, Memorial Sloan-Kettering Cancer Center, New York, NY |
| 8:15 |
Lobular Carcinoma in Situ: Past, Present and Future - Timothy W. Jacobs, Virginia Mason Medical Center, Seattle, WA |
| 8:45 |
Clinical Management of High Risk Breast Lesions: What a Medical Oncologist Needs from Pathology - Julie R. Gralow, University of Washington, Seattle, WA |
| 9:15 | Question and Answer Session |
| 9:55 | Closing Remarks |
| Topics were determined by the executive committee of the International Society of Breast Pathology. The selection of topics takes into consideration previous companion meeting presentations, the needs of society members and the general audience, and recent advances in the field of breast pathology. The topics provide updates for practicing pathologists and trainees on advances in histopathologic features of in-situ carcinomas of breast, role of molecular markers in classification of in situ lesions, and clinical management of high risk lesions of breast. |
|
|


|